These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7482720)

  • 21. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of intrathymic tolerance with intrathymic chimerism in neonatally tolerized mice.
    Morrissey PJ; Sharrow SO; Kohno Y; Berzofsky JA; Singer A
    Transplantation; 1985 Jul; 40(1):68-72. PubMed ID: 4012844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
    J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal transplantation tolerance is associated with a systemic reduction in memory cells, altered chimeric cell phenotype, and modified eicosanoid and cytokine production.
    Ruiz P; Nassiri M; Gregorian S; Viciana AL; Streilein JW
    Transplantation; 1996 Apr; 61(8):1198-205. PubMed ID: 8610418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed chimerism, heart, and skin allograft tolerance in cyclophosphamide-induced tolerance.
    Zhang QW; Tomita Y; Matsuzaki G; Yoshikawa M; Shimizu I; Nakashima Y; Sueishi K; Nomoto K; Yasui H
    Transplantation; 2000 Sep; 70(6):906-16. PubMed ID: 11014644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B-->A) to secondary recipients.
    Wren SM; Hronakes ML; Ildstad ST
    Transplantation; 1992 Dec; 54(6):1031-40. PubMed ID: 1465769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivity.
    Carrier E; Gilpin E; Lee TH; Busch MP; Zanetti M
    J Lab Clin Med; 2000 Sep; 136(3):224-35. PubMed ID: 10985501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of intrathymic mixed chimerism for the maintenance of skin allograft tolerance across fully allogeneic antigens in mice.
    Eto M; Kong YY; Uozumi J; Naito S; Nomoto K
    Immunology; 1999 Mar; 96(3):440-6. PubMed ID: 10233726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.
    Strober S; Benike C; Krishnaswamy S; Engleman EG; Grumet FC
    Transplantation; 2000 Apr; 69(8):1549-54. PubMed ID: 10836360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation.
    Donahue J; Gilpin E; Lee TH; Busch MP; Croft M; Carrier E
    Transplantation; 2001 Feb; 71(3):359-68. PubMed ID: 11233894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation.
    Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
    Transplantation; 2000 Apr; 69(7):1242-51. PubMed ID: 10798737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
    Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
    J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.
    Neipp M; Exner BG; Ildstad ST
    Transplantation; 1998 Oct; 66(8):969-75. PubMed ID: 9808477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimerism but not neonatal antigen exposure induces transplant tolerance.
    Peiguo Z; Shijie Z; Liang M
    Scand J Immunol; 2012 Aug; 76(2):108-12. PubMed ID: 22537091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infusion of donor hepatic non-parenchymal cells prolongs survival of skin allografts in mice: role of microchimerism and IL-4.
    Ding XM; Xue WJ; Ji ZZ; Tian PX
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):34-7. PubMed ID: 17287163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.